Diar Pharmaceuticals Private Limited
About Diar Pharmaceuticals Private Limited
Data last updated:
Diar Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 07 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC289410. Its GSTIN is 07AAFCD5961R1ZX (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mukesh Kumar Koiry and Ravi Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Wz – 90 F/F Jwala Heri Paschim Vihar, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.46 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹57,003 (net margin -3.7%) and EBITDA of -₹57,003 (EBITDA margin -3.7%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 65% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Diar Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressWz – 90 F/F Jwala Heri Paschim Vihar, New Delhi, Delhi, India – 110063
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Diar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Diar Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Diar Pharmaceuticals Private Limited, buy the company report.
Financials of Diar Pharmaceuticals Private Limited
FY 2022 filings availableDiar Pharmaceuticals Private Limited reported revenue of ₹15.46 Lakh (down 19% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 65%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹57,003 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹57,003 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.7% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Diar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Diar Pharmaceuticals Private Limited
Diar Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Koiry | Director | 07 Jan 2016 | 10 Years 10 Months | Current |
| Ravi Kumar | Director | 13 Oct 2018 | 8 Years 0 Months | Current |
| Nitin Chauhan | Director | 21 May 2019 | 7 Years 5 Months | Current |
| Girish Sharma | Director | 14 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Diar Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mipro Pharmaceuticals Private Limited | ₹15.62 Lakh (FY 2024) | 16.0% | Lajpat Nagar, Delhi, India | |||
| Narzi Pharmaceuticals Private Limited | ₹15.51 Lakh (FY 2022) | 1634.0% | Nalbari, Assam, India | |||
| Diar Pharmaceuticals Private Limitedthis company | ₹15.46 Lakh (FY 2022) | -₹57,003 | -3.7% | -19.0% | New Delhi, Delhi, India | |
| Magadh Pharmaceuticals Private Limited | ₹15.44 Lakh (FY 2024) | -6.0% | Patna, Bihar, India | |||
| Ybrex Pharmaceuticals Private Limited | ₹15.35 Lakh (FY 2024) | -1.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Diar Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Diar Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Diar Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Diar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Diar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Diar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD5961R1ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Diar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Diar Pharmaceuticals Private Limited has 8 board changes on record since 2016: 6 appointments and 2 cessations. The latest: Nitin Chauhan was appointed as Director on 21 May 2019.
Frequently asked questions
Diar Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 07 January 2016 (10+ years old) and is registered under CIN U74999DL2016PTC289410.
Diar Pharmaceuticals has 4 current directors:
- Mukesh Kumar Koiry - Director
- Ravi Kumar - Director
- Nitin Chauhan - Director
- Girish Sharma - Director
The latest financial statements of Diar Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Diar Pharmaceuticals is 07AAFCD5961R1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Diar Pharmaceuticals is U74999DL2016PTC289410. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Diar Pharmaceuticals was incorporated on 07 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Diar Pharmaceuticals by revenue are Mipro Pharmaceuticals Private Limited, Narzi Pharmaceuticals Private Limited, Magadh Pharmaceuticals Private Limited, Ybrex Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nitin Chauhan was appointed as Director on 21 May 2019. Girish Sharma was appointed as Director on 14 May 2019. Prince Kumar ceased to be Director on 14 May 2019. Diar Pharmaceuticals has 8 board changes on record in total.
The registered office of Diar Pharmaceuticals is at Wz – 90 FF Jwala Heri Paschim Vihar, New Delhi, Delhi, India – 110063.
Diar Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Diar Pharmaceuticals is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
